PERIPHERAL BLOOD STEM CELL TRANSPLANTATION
Clinical trials for PERIPHERAL BLOOD STEM CELL TRANSPLANTATION explained in plain language.
Never miss a new study
Get alerted when new PERIPHERAL BLOOD STEM CELL TRANSPLANTATION trials appear
Sign up with your email to follow new studies for PERIPHERAL BLOOD STEM CELL TRANSPLANTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a lower dose of a transplant drug be better for blood cancer patients?
Disease control Recruiting nowThis study is for people with blood cancers like leukemia or lymphoma who need a stem cell transplant from a donor. After transplant, a drug called cyclophosphamide is given to prevent a serious side effect called graft-versus-host disease, but high doses can cause problems. The …
Matched conditions: PERIPHERAL BLOOD STEM CELL TRANSPLANTATION
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New drug combo aims to stop leukemia relapse after transplant
Disease control Recruiting nowThis study tests whether adding two drugs, ruxolitinib and chidamide, to the standard chemo given before a stem cell transplant can lower the chance of leukemia coming back. It includes 50 people aged 12 to 65 with high-risk B-cell acute lymphoblastic leukemia who have a suitable…
Matched conditions: PERIPHERAL BLOOD STEM CELL TRANSPLANTATION
Phase: PHASE2 • Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated May 11, 2026 20:38 UTC